Infectious Diseases News

Data from more than 3 million participants in the National COVID Cohort Collaborative revealed that SARS-CoV-2 reinfections have similar severity to initial infections.

The CDC said it has confirmed four new cases of highly pathogenic avian influenza in Colorado poultry workers and is aware of a fifth presumptive-positive case.

The severity of a SARS-CoV-2 reinfection is likely to be similar to the severity of a patient’s initial infection, researchers found.

Socioeconomic disparities among residential neighborhoods may be associated with the prevalence of five specific antimicrobial-resistant organisms, especially AmpC beta-lactamase producers and methicillin resistant Staphylococcus aureus.

A first-in-human trial of a nasal COVID-19 vaccine candidate began enrolling adults aged 18 to 64 years who have received at least three prior doses of a COVID-19 messenger RNA vaccine, according to the NIH.

At a time when sexually transmitted infections have been described as an epidemic, primary care providers should counsel specific patients on doxycycline for post-exposure prophylaxis, according to an expert.

CHICAGO — Antioxidant therapies showed varying levels of effectiveness when used as a treatment for COVID-19, according to results of a recent systematic review and meta-analysis presented at NUTRITION.

The monoclonal antibody nirsevimab reduced the risk that infants would be hospitalized for respiratory syncytial virus-associated bronchiolitis, according to a study published Wednesday in The New England Journal of Medicine.

The FDA’s recent authorization of a rapid, point-of-care test to diagnose current hepatitis C virus infection is a major victory, but it would be malpractice to initiate same-day HCV treatment if a patient’s hepatitis B virus status is unknown.

A 15-day course of Paxlovid demonstrated no significant benefit for patients with post-acute sequelae of SARS-CoV-2 infection, according to data published in JAMA Internal Medicine.